A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older.
about
The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adultsSeasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics - a systematic literature reviewDecreased serologic response in vaccinated military recruits during 2011 correspond to genetic drift in concurrent circulating pandemic A/H1N1 viruses.Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccinesPrevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season.A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individualsInfluence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial.Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza.Cutting edge: rapid boosting of cross-reactive memory CD8 T cells broadens the protective capacity of the Flumist vaccine.Mucosal immunity and nasal influenza vaccination.Assessing vaccine efficacy in influenza clinical trials: challenges and difficulties.The global challenge and future strategies for keeping the world's aging population healthy by vaccination.Vaccination in the prevention of infectious respiratory diseases in adults.Influenza vaccines: Evaluation of the safety profile.
P2860
Q24622008-0E211720-5A40-4517-B11A-37447F759E2EQ26769664-5281E37C-9EBE-44DC-9BF7-0E555858F1BEQ30415565-9F3C8CC1-ABB7-458B-A72D-002AF7F4A346Q34354440-8F5D7941-E893-48BF-ABF0-16D91C7372C4Q34433508-CF42D170-BDF0-4F06-A436-907259736539Q35815281-F95D4F6C-D9B2-4723-9B0B-32F0977B34D3Q35862144-C6F86981-BD12-4B88-9744-16D0356723A1Q36482772-7A6D56CA-D897-46E2-9701-2AACBE25E4BFQ36754401-91099EA7-D31E-4CCA-8EA0-B0F45160AF0AQ38028996-D730E25E-7533-4EB5-8142-FEE1CB665AFDQ38127468-586CC6C8-49CD-4CDD-AE13-874EE7F16B66Q38822152-C9A0A176-7791-40DC-A4FC-387FA0F829CAQ42210967-A754E807-95B0-4961-8D50-04B001342356Q49345779-C295E07F-B73A-4E2C-B784-4141A7BE5DE7
P2860
A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A prospective, randomized, ope ...... lts 60 years of age and older.
@en
type
label
A prospective, randomized, ope ...... lts 60 years of age and older.
@en
prefLabel
A prospective, randomized, ope ...... lts 60 years of age and older.
@en
P2093
P1433
P1476
A prospective, randomized, ope ...... lts 60 years of age and older.
@en
P2093
A Duncan Steele
Bruce D Forrest
Louis Hiemstra
Ruth Rappaport
William C Gruber
P304
P356
10.1016/J.VACCINE.2011.03.029
P407
P577
2011-04-05T00:00:00Z